WaveMan · Form 4
Engleman Edgar insider trades
> Search tickers & screens ⌘K
LIVE

Engleman Edgar insider trades

Engleman Edgar has filed 6 Form 4s with the SEC that we hold, all for Bolt Biotherapeutics, Inc. (BOLT), as Director. Across all of them we count 0 purchases worth $0 and 12 sales worth $176.8K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 108,145 shares of Bolt Biotherapeutics, Inc. worth $93.0K, dated 2023-11-30. The first filing on our record is dated 2022-03-28 and the latest 2023-12-01.

Bolt Biotherapeutics, Inc. (BOLT)

Director · 6 filings · 12 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-11-16S, sale reported on Form 41,040$9982023-11-20
2023-11-16S, sale reported on Form 47,531$7.2K2023-11-20
2023-11-17S, sale reported on Form 41,134$1.1K2023-11-20
2023-11-17S, sale reported on Form 48,211$7.6K2023-11-20
2023-11-20S, sale reported on Form 43,792$3.5K2023-11-20
2023-11-20S, sale reported on Form 427,465$25.3K2023-11-20
2023-11-21S, sale reported on Form 4236$2122023-11-22
2023-11-21S, sale reported on Form 41,707$1.5K2023-11-22
2023-11-29S, sale reported on Form 422,674$20.6K2023-12-01
2023-11-29S, sale reported on Form 43,131$2.8K2023-12-01
2023-11-30S, sale reported on Form 414,934$12.8K2023-12-01
2023-11-30S, sale reported on Form 4108,145$93.0K2023-12-01
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1227162) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms